<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04519060</url>
  </required_header>
  <id_info>
    <org_study_id>CHLA-20-00211</org_study_id>
    <nct_id>NCT04519060</nct_id>
  </id_info>
  <brief_title>Eye Shields for Infants After Dilated Exam</brief_title>
  <official_title>An Eye-opener: The Impact of Eye Shields for Infants After Dilated Exam</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Children's Hospital Los Angeles</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Children's Hospital Los Angeles</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The eyes of hospitalized infants are often assessed by dilated exam, and there is evidence&#xD;
      that infants experience post-exam stress. Investigators will evaluate whether eye shields for&#xD;
      infants after dilated eye exam lessen stress and discomfort.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neonatal eye examinations are the standard of best practice in pediatrics. In the acute&#xD;
      clinical setting, infants' eyes are inspected for eye development, defect, and disease. There&#xD;
      is anecdotal and clinical evidence that infants experience stress after eye dilation.&#xD;
      Investigators will evaluate whether eye shields for infants after dilated eye exam lessen&#xD;
      stress and discomfort.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of stress events</measure>
    <time_frame>4-6 hours (from first dose of eye dilating medication to four hours after last dose)</time_frame>
    <description>The primary outcome will be measured by the count of apneas and bradycardias (stress events) experienced by the infant during the period of eye dilation without eye shields as compared to the total stress events experienced when dilated eyes are covered with eye shields.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of stress events amongst covariates</measure>
    <time_frame>4-6 hours (from first dose of eye dilating medication to four hours after last dose)</time_frame>
    <description>The secondary outcome measure will be abstracted from covariate data (e.g., infant gestational age at birth, post-natal age, weight, and ventilation status) to assess the influence of covariables on the response to eye shields as an intervention to lessen stress and discomfort in hospitalized infants after dilated eye exam.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">106</enrollment>
  <condition>Infant, Newborn, Disease</condition>
  <condition>Pain</condition>
  <condition>Retinopathy of Prematurity</condition>
  <condition>Eye Diseases</condition>
  <arm_group>
    <arm_group_label>No eye shields after dilated eye exam</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Eye dilation for scheduled exam will be followed by routine clinical care.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Eye shields after dilated eye exam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eye dilation for scheduled exam will be followed by routine clinical care and the application of eye shields. They will be worn until four (4) hours after the last dose of dilating eye drops.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>phototherapy eye shield</intervention_name>
    <description>Phototherapy eye shields will be applied to the eyes of infants dilated for scheduled eye exam. They will be worn until four (4) hours after the last dose of dilating eye drops.</description>
    <arm_group_label>Eye shields after dilated eye exam</arm_group_label>
    <other_name>phototherapy eye protector</other_name>
    <other_name>phototherapy eye mask</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Chronological age 0-12 months&#xD;
&#xD;
          -  Infants who require dilated eye exams&#xD;
&#xD;
          -  Parent or legal guardian consent/permission granted&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  More than a two-week interval between dilated eye exams&#xD;
&#xD;
          -  Prior or ongoing medical treatment or therapy for the eye(s)&#xD;
&#xD;
          -  Functional blindness diagnosed by eye exam&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Year</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Maxine Ogbaa, BSN</last_name>
    <phone>323-361-2531</phone>
    <email>mogbaa@chla.usc.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Heidi Machen, PHN, BSN</last_name>
    <phone>323-361-2531</phone>
    <email>hmachen@chla.usc.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Children's Hospital Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90027</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Maxine Ogbaa, BSN</last_name>
      <phone>323-361-2531</phone>
      <email>mogbaa@chla.usc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Heidi Machen, PHN, BSN</last_name>
      <phone>323-361-2531</phone>
      <email>hmachen@chla.usc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Maxine Ogbaa, BSN</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Heidi Machen, PHN, BSN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>May 17, 2020</study_first_submitted>
  <study_first_submitted_qc>August 17, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 19, 2020</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Children's Hospital Los Angeles</investigator_affiliation>
    <investigator_full_name>Maxine Ogbaa</investigator_full_name>
    <investigator_title>BSN</investigator_title>
  </responsible_party>
  <keyword>eye shield</keyword>
  <keyword>eye protector</keyword>
  <keyword>eye patch</keyword>
  <keyword>eye mask</keyword>
  <keyword>phototherapy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Eye Diseases</mesh_term>
    <mesh_term>Retinopathy of Prematurity</mesh_term>
    <mesh_term>Infant, Newborn, Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

